Topiramate Tablet
Product Images NDC 70518-1196

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70518-1196). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Topiramate 100 mg oral tablets in a quantity of 30, repackaged by RemedyRepack Inc. The label includes the NDC number 70518-1196-00 and manufacturing information from Cipla USA, Inc. It advises keeping medication out of reach of children and refers to the package insert for directions for use. Storage temperature guidelines are also noted.*

FDA Label Image

Topiramate 100mg 70518 1196 01

Topiramate 100 mg oral tablets packaging label showing quantity of 30 tablets. Label includes text indicating prescription use, a barcode, QR code, manufacturer information (Cipla USA, Inc., Miami, FL), and repackaging details by Remedy Repack Inc. Storage instructions and a package insert reference are also visible.*

FDA Label Image

Topiramate 100mg 70518 1196 02

Topiramate 100 mg oral tablet single unit label by RemedyRepack Inc. The label includes prescription information with the NDC 70518-1196-02, manufacturer Cipla USA, and storage instructions. The label also notes repackaging by RemedyRepack in Indiana, PA.*

FDA Label Image

Topiramate 100mg 70518 1196 03

Topiramate 100 mg tablet packaging label showing a quantity of 100 tablets. The label names RemedYRepack Inc. as the repackager with manufacturing by Cipla USA, Inc. Directions advise storing the product between 20-25°C with permitted excursions. The label includes barcode, QR code, and a warning to keep medication out of children's reach.*

FDA Label Image

Topiramate 100mg 70518 1196 04

Topiramate 100 mg tablet single unit packaging label shows product name, strength, dosage form, and quantity of 1 tablet. Labeler is RemedyRepack Inc. The label includes RX only status, an NDC number, manufacturer Cipla USA, and storage instructions with repackager contact information.*

FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01

Chemical structure diagram of topiramate, showing its molecular arrangement including oxygen, sulfur, nitrogen, and carbon atoms with distinct functional groups.*

FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02

A line graph showing cumulative rates for time to first seizure over days, comparing two Topiramate dosages: 50 mg/day and 400 mg/day. The x-axis represents time in days up to 500, and the y-axis represents cumulative rates up to 0.50. Two curves depict different dose groups with their respective sample sizes (N=234 and N=236), and a statistical p-value of 0.0002 is noted.*

FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03

A bar graph comparing the change from baseline to double-blind phase in average monthly migraine periods for placebo and Topamax (topiramate) at doses of 50 mg/day, 100 mg/day, and 200 mg/day across two studies (Study 10 and Study 11). The graph shows decreases in migraine periods with increasing Topamax dosage, with statistical significance indicated for higher doses.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.